Materials • Major Chemicals
$8.97 ▼ -0.14
(-1.54%)
MKT CAP: $1.57B • VOL: 2.32M
52W L $7 52W H $16
HUN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.68B | $6.04B | $6.11B |
| YoY Revenue Growth % | -5.8% | -1.2% | — |
| Gross Profit | $751.0M | $866.0M | — |
| Gross Margin % | 13.2% | 14.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$131.0M | -$25.0M | $84.0M |
| Operating Margin % | -2.3% | -0.4% | 1.4% |
| Net Income (GAAP) | -$284.0M | -$189.0M | $101.0M |
| EBITDA (Normalized) | $7.4M | $122.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $289.0M | $263.0M | $209.0M |
| Capital Expenditures (CapEx) | $173.0M | $184.0M | — |
| Free Cash Flow (FCF) | $116.0M | $79.0M | $209.0M |
| FCF Margin % | 2.0% | 1.3% | 3.4% |
| Return on Invested Capital (ROIC %) | -2.6% | -0.5% | — |
| Cash & Short-Term Equivalents | $429.0M | $340.0M | — |
| Total Debt (Short + Long Term) | $1.66B | $1.51B | — |
| Total Stockholders' Equity | $2.75B | $2.96B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR HUN.